Mesenteric Ischemia Markers Study
Mesenteric Ischemia Markers Study In The Presence Of Mesenteric Arteries Disease
- Mesenteric Vascular Disease
At a glance
- Phase
- Phase not stated
- Study type
- Interventional
- Sponsor
- Belarusian State Medical University
- Enrolment target
- 120
- Started
- 22 December 2025
- Main results due
- 12 September 2026
- Study sites
- 1
- Registry updated
- 23 September 2026
Can you take part?
- Aged 18 years and over.
- Open to any sex.
- Healthy volunteers can take part.
These are the headline rules only. Every study has a longer list, and whether you are eligible is decided by the research team at the site — never by this page.
Read the full eligibility criteria
Inclusion Criteria: * 18 years or older, all sex * Initial decision, the presence of angio-visualisation of the MA and suspicion of mesenteric arteries diseases * Patient's consent to participate in the study * No pregnancy, no history of major operations on MA, the gastrointestinal tract and digestive organs (except appendectomy, endoscopic polypectomy). Exclusion Criteria: * Consent declined by patient or relatives * Failure to meet inclusion criteria
What this study is about
In the sponsor’s own words, from the registry.
Vascular bowel disease remains a socially significant and potentially fatal condition (if it develops into AMI), primarily due to delayed diagnosis. Blood biomarkers are theoretically ideal for early risk stratification (like troponins in myocardial infarction). However, the existing evidence base is characterized by low quality and high heterogeneity, which hinders their use in clinical practice. Therefore, there is an urgent and unmet clinical need for high-quality, methodologically rigorous research to validate biomarkers in MI. A current study (MESMARK) is to be undertaken to identify combinations of biomarkers that can reliably identify mesenteric ischemia (MI) and distinguish between non-transmural and transmural clinical relevant ischemia.
Study sites(1)
Belarusian State Medical University
Minsk, Belarus
Recruiting
Showing 1 of 1 sites. 1 of the 1 site on this study is recruiting right now — a site can stop enrolling while the study as a whole is still open.
Source: ClinicalTrials.gov record NCT07460700. Trialion does not run this study, is not paid to refer anyone to it, and cannot enrol you. Eligibility is always decided by the research team at the site.
Not the right study?
Answer three questions and see the studies recruiting near you, in plain language.
Find a study for me